
MDU Resources reports US$14M quarterly profit and keeps earnings outlook
Electric utility earnings rose, while MDU narrowed Bakken East's estimated capital investment to US$2.8B to US$3.1B.

The award adds a technology-development phase, but AST discloses no contract value, funded amount or delivery schedule.

Electric utility earnings rose, while MDU narrowed Bakken East's estimated capital investment to US$2.8B to US$3.1B.

The buyer expects closing in the coming weeks and says future computing demand would be supported by additional generation.
Brooks campus closing requires a credit-backed customer contract and committed financing, while the proposed debt funding remains an expectation.
Promontorio Sur returned 12.20 metres at 238 grams per tonne silver equivalent, with an updated resource targeted for the fourth quarter.

The New Zealand proposal seeks mine and infrastructure approvals, with a feasibility study targeted for the fourth quarter of 2026.

Quarter-end cash, restricted cash and deposits totalled US$840.6 million before the October CanAdelaar acquisition.

Assays confirm mineralization 500 metres beyond the deposit and higher grades inside Hurricane's southern resource shell.

The developer has about US$780 million in unrestricted cash and expects its first HPC revenue in 2027.
Armenia's conditional authorizations cover previously treated metastatic colorectal cancer; existing financing supports operations into 2027.
The planned sale excludes EES Coke, while DTE’s 2027 earnings baseline assumes a closing earlier than the announced target.
The pipeline operator sets a 2027 net capital spending range of C$6B to C$6.5B and approves Midwest expansions targeting 2030 service.
Shoals holders would receive 1.6931 ARRAY shares per share and own about 65% of the combined company, with closing targeted for early 2027.
A US$36M tariff benefit lifted gross margin, while net cash and investments slipped and fourth-quarter sales guidance came in lower.
A definitive Fluor construction agreement covers three Kentucky buildings, with phased completions expected from late 2027 through mid-2028.
Management estimates up to US$2.5 million in additional survey work over two years, subject to successful delivery and further awards.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The proposed share deal would give Aya about 19.11 per cent of Sama and add Moroccan tungsten, copper and molybdenum exposure.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The 353-patient VOCAL study tested three-times-weekly vadadustat, a regimen that remains investigational despite Vafseo's daily-use approval.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Quarterly capital spending reached US$985.1 million, while the company targets early 2027 completion of its first colocation buildout.
Medical-only quarterly results limit year-over-year comparisons as Trulieve reports a US$65 million mortgage repayment after September.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Available liquidity stood near US$700M at Sept. 30 as the company advanced a US$2.3B Great Basin expansion targeting service in late 2028.

The Anais dyke interval includes 142 metres at 1.97 per cent lithium oxide, with true thickness estimated at about 80 per cent of drilled length.

The generator forecasts US$1.5B to US$1.75B in adjusted free cash flow for 2027 as acquired plants contribute a full year.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cash reached US$48.2 million as licensing supported operations, while approaching hemp restrictions threaten current products.

The company identifies its entire Florida retail network, while federal security, inventory and recordkeeping requirements continue.

The psilocybin developer expects its final application submission within two weeks, with a launch targeted for the first half of 2027.

The company confirms federal registrations but does not disclose how many dispensaries received them or identify their locations.